Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea
Tóm tắt
Từ khóa
Tài liệu tham khảo
Astrup A. The sympathetic nervous system as a target for intervention in obesity. Int J Obes Relat Metab Disord 19 Suppl 7: S24–S28, 1995.
Astrup A, Breum L, Toubro S, Hein P, and Quaade F. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy-restricted diet. A double blind trial. Int J Obes 16: 269–277, 1992.
Astrup A and Toubro S. Thermogenic, metabolic, and cardiovascular responses to ephedrine and caffeine in man. Int J Obes Relat Metab Disord 17 Suppl 1: S41-S43, 1993.
Bray GA. Autonomic and endocrine factors in the regulation of energy balance. Fed Proc 45: 1404–1410, 1986.
Bray GA. Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications. Int J Obes 24 Suppl 2: S8–S17, 2000.
Bukowiecki L, Jahjah L, and Follea N. Ephedrine, a potential slimming drug, directly stimulates thermogenesis in brown adipocytes via beta-adrenoreceptors. Int J Obes 6: 343–350, 1982.
Chen MD, Lin WH, Song YM, Lin PY, and Ho LT. Effect of caffeine on the levels of brain serotonin and catecholamine in the genetically obese mice. Zhonghua Yi Xue Za Zhi (Taipei) 53: 257–261, 1994.
Dulloo AG. Ephedrine, xanthines and prostaglandin-inhibitors: actions and interactions in the stimulation of thermogenesis. Int J Obes Relat Metab Disord 17 Suppl 1: S35-S40, 1993.
Dulloo AG and Jacquet J. An adipose-specific control of thermogenesis in body weight regulation. Int J Obes Relat Metab Disord 25 Suppl 5: S22–S29, 2001.
Dulloo AG and Miller DS. The thermogenic properties of ephedrine/methylxanthine mixtures: human studies. Int J Obes 10: 467–481, 1986.
Dulloo AG, Seydoux J, and Girardier L. Peripheral mechanisms of thermogenesis induced by ephedrine and caffeine in brown adipose tissue. Int J Obes 15: 317–326, 1991.
Henry CJ and Emery B. Effect of spiced food on metabolic rate. Hum Nutr Clin Nutr 40: 165–168, 1986.
Horton TJ and Geissler CA. Post-prandial thermogenesis with ephedrine, caffeine and aspirin in lean, pre-disposed obese and obese women. Int J Obes Relat Metab Disord 20: 91–97, 1996.
Landsberg L and Young JB. Diet and the sympathetic nervous system: relationship to hypertension. Int J Obes 5 Suppl 1: 79–91, 1981.
Landsberg L and Young JB. Sympathoadrenal activity and obesity: physiological rationale for the use of adrenergic thermogenic drugs. Int J Obes Relat Metab Disord 17 Suppl 1: S29–S34, 1993.
Macdonald IA. Advances in our understanding of the role of the sympathetic nervous system in obesity. Int J Obes Relat Metab Disord 19 Suppl 7: S2–S7, 1995.
Pasquali R, Baraldi G, Cesari MP, Melchionda N, Zamboni M, Stefanini C, and Raitano A. A controlled trial using ephedrine in the treatment of obesity. Int J Obes 9: 93–98, 1985.
Pasquali R, Cesari MP, Melchionda N, Stefanini C, Raitano A, and Labo G. Does ephedrine promote weight loss in low-energy-adapted obese women? Int J Obes 11: 163–168, 1987.
Rados C. Ephedra ban: no shortage of reasons. FDA Consum 38: 6–7, 2004.
Ravussin E. Low resting metabolic rate as a risk factor for weight gain: role of the sympathetic nervous system. Int J Obes Relat Metab Disord 19 Suppl 7: S8–S9, 1995.
Roomi MW, Roomi N, Ivanov V, Kalinovsky T, Niedzwiecki A, and Rath M. Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis. Oncol Rep 14: 807–815, 2005.
Saper RB, Eisenberg DM, and Phillips RS. Common dietary supplements for weight loss. Am Fam Physician 70: 1731–1738, 2004.
Sartippour MR, Heber D, Henning S, Elashoff D, Elashoff R, Rubio R, Zhang L, Norris A, and Brooks MN. cDNA microarray analysis of endothelial cells in response to green tea reveals a suppressive phenotype. Int J Oncol 25: 193–202, 2004.
Sartippour MR, Heber D, Zhang L, Beatty P, Elashoff D, Elashoff R, Go VL, and Brooks MN. Inhibition of fibroblast growth factors by green tea. Int J Oncol 21: 487–491, 2002.
Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, and Gagne J. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 289: 1537–1545, 2003.
Toubro S, Astrup AV, Breum L, and Quaade F. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans. Int J Obes 17 Suppl 3: S73–S77, 1993.
Toubro S, Astrup AV, Breum L, and Quaade F. safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture. Int J Obes 17 Suppl 1: S69–S72, 1993.
Tsuchida T, Itakura H, and Nakamura H. Leptin: fundamental aspects. Prog Med 22: 2189–2203, 2002.
World HE. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894: i-xii, 1–253, 2000.
Yoshida T, Sakane N, Umekawa T, and Kondo M. Relationship between basal metabolic rate, thermogenic response to caffeine, and body weight loss following combined low calorie and exercise treatment in obese women. Int J Obes 18: 345–350, 1994.
Yoshioka M, St-Pierre S, Drapeau V, Dionne I, Doucet E, Suzuki M, and Tremblay A. Effects of red pepper on appetite and energy intake. Br J Nutr 82: 115–123, 1999.
Young JB and Macdonald IA. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes Relat Metab Disord 16: 959–967, 1992.
Zheng G, Sayama K, Okubo T, Juneja LR, and Oguni I. Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. In Vivo 18: 55–62, 2004.